Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Sweden
Finland
Denmark
Norway
Latest
Trending
Followed

Probi, Audiocast with teleconference, Q2'24

By Inderes7/16/2024, 8:00 AM
Probi

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Anita Johansen
00:00 - 02:07

Good morning. Welcome, and thank you for dialing in to this presentation of our quarter two results for 2024. With me, I have Colin Powell, the CFO of Probi, and my name is Anita Johansen and I'm the CEO of Probi. Please take a few moments to familiarize yourself with this statement. And this is the agenda of our presentation today. Here are the highlights of the second quarter, which was a busy quarter marked by significant progress. The net sales were 179 million Swedish crowns, which was a 25% increase versus the same quarter last year. Net sales in the first half of the year are in line with our expectations. The EBITDA margin for the second quarter was 19%, which is 10 percentage points up versus the second quarter last year. In May, the annual general meeting decided on a 1.30 Swedish kronor per share dividend. And let's go to our business operations. The quarter was busy. We continue to streamline and adapt the organization to facilitate growth and profitability. Our partnership with Methods went live, making Probi's consumer products available in Denmark, and the Probi product received further validation by a fourth study, focusing on good brain health in older adults over the age of 70 years. We also entered a partnership with Bauer to incentivize recycling of consumer packaging in the Nordic markets of Sweden and Norway. We launched the first ever China Innovation Day, which ignited considerable interest among our customers in China, and our customer product pipeline is growing as a result of generally high commercial activity. Now, I'll hand over to Per Lindblad for the financial review.

Per Lindblad
02:09 - 06:40

Thank you, Anita. A strong business performance. In Q2, we reported sales growth of 25% and an EBITDA margin of 19%. The strong Q2 sales are due to favorable comparisons, but also underlying growth in America and EMEA, where I will show more specifics shortly. The EBITDA margin for Q2 is 19% and brings the H1 margin up to 17%, which is at level with full year 23 and aligned with our expectations. Now, the regional segment reporting for H1 Americas was impacted by quarter to quarter timing and the outcome is reported growth for H1, with sales up 2% and organic growth up 1%. Behind this is lots of activity by the commercial team. Examples include showcasing our most recent innovations at the Supply Side West trade show and also at Digestive Disease Week in Washington, D.C. The gross profit margin in America was impacted by added resources in operations to facilitate improvements to production. The added resources involved both internal and external consultants, as well as investments in tangible equipment. The initial results are very promising, and we are confident that the investments made will pay off in 2025 and beyond. Next is EMEA. EMEA had very strong sales in Q2, which built on strong Q1 sales. Also, H1 is now up 48% year over year. Note though, that last year we reported inventory corrections with a major EMEA account after the Covid pandemic normalization and also the insourcing of the B2C business in Sweden, which implied lower sales in Q2 last year and this year. Both have normalized, and EMEA is on top of this, showing underlying growth and has secured a few new business wins. The sales growth, with maintained high margins, implies an overall gross profit in EMEA is up by 10 million Swedish Krona in H1. APAC sales in both Q1 and Q2 have been adversely impacted by the cross-border business sales into China being significantly reduced compared to 2023. This is impacting all players in the market, including Probi. All the major accounts were exposed to timing driven by both inventory positions and launches. Despite the lower sales than last year, the competitive position of Probi has been maintained, and gross profit is noted, impacted by an adverse product mix for H1. Now, the net income for Q2 is here broken out by the various drivers and shows that the volume effect is the real underlying driver. This is in line with the comments made earlier, specifically regarding sales timing in the Americas and EMEA. Continued investment of 27 million Swedish Krona for both plant, machinery, and equipment to drive efficiencies, but also R&D projects to support the sales pipeline. On top of this, we paid our dividend of 15 million as decided by the AGM. Noted, though, that the continued strong operating cash flow of 23 million and Probi has by this maintained an overall strong cash position. A quick look at the balance sheet. This is mainly a slide to remind you of the strong balance sheet of Probi. With this, I'd like to give back the word to Anita Johansen.

Unknown 1
06:41 - 06:41

Thank you.

Anita Johansen
06:42 - 07:53

So, summarizing our quarterly financial report, it is fair to say that we are progressing in the right direction. And that quarter two marked a positive milestone. Verifying progress. Reinforce strategy. We are currently on track to meet our targets for the full year, which are largely expected to be in line with last year's results. We are still in an ongoing transition period, working diligently to implement essential changes and improvements to achieve long-term strength. Our organizational capabilities and ways of working have improved. Our commercial activities are also high within the organization, which has resulted in a positively trending customer project pipeline, and production optimizations are progressing according to plan; initial data shows positive results. We will maintain our strategic focus while implementing important changes and improvements during the ongoing transition. This concludes our presentation of our second quarter interim report for 2024. Now there's time for questions.

Operator
07:56 - 08:25

If you wish to ask a question, please dial Pound Key five on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial Pound Key six on your telephone keypad. The next question comes from Philip Eichengreen from ABG Sundal Collier. Please go ahead.

Unknown 2
08:26 - 08:49

Karen. Thank, you. It's really nice to see such good progress here. I have a few questions, and I plan to take them one by one. I hope that's okay. Um, so first you write that you're making efforts to improve internal processes and production alongside the commercial incentives. Could you please expand on this? What type of improvements do you expect, and can we expect a margin improvement at the end of the year?

Anita Johansen
08:51 - 09:23

Good morning, Phillip, and thank you for your question. First of all, I will say our optimization and manufacturing is a catalogue of projects. So it's different projects. It's several projects to improve our ways of working and also it's process optimizations. And as I already said, we're making steady progress and our data shows positive results. But we do not expect a notable impact until the end of the year at the earliest. So we are not expecting it to be visible in 2024.

Unknown 2
09:25 - 09:45

Okay, perfect. Thank you very much. Um, and the next question concerns this year's goal of staying largely in line with 2023, as you write in the report. But could you explain a bit what 'in line' means? So is the goal to stay in line on sales or margin or EBITDA on absolute terms?

Per Lindblad
09:50 - 10:48

Yes, I think I used the term 'in line' specifically for the EBITDA margin. Okay. And then we have, as you know well, a lot of quarter-to-quarter variation, and with the 19% reported in Q2, we are on a year-to-date basis at 17%, which is in line with the full year last year. So I think it's important we should look not only at the quarters but also in the aggregate. <r /> So for each instance and the same for sales, we see variations in sales. We had a relatively weak sales period in Q1 with high comparisons. And in Q2, we had an excellent quarter. But again, I think H1 is the most important takeaway. And sales here are at 4.8%, which is a good number considering the market dynamics.

Unknown 1
10:52 - 10:52

Huh?

Unknown 2
10:53 - 11:14

Uh, great. Thank, you. Um, if we move on to the strength in EMEA, uh, you explained it partly by addressing e-commerce, but also the strength in the B2C leg. Could you elaborate on how much of the growth is attributable to B2C, and if other parts of EMEA are also moving in the right direction, so to say.

Per Lindblad
11:18 - 12:10

Yes, as you know, our segmental report is regional. So we are not providing specific data below that. But we are giving some insights. And the insight is that our B2C business is doing well and is growing compared to previous years. We are especially happy with the insourcing of the business, as we executed last year, which is performing well. And that is helping us to invest even more in marketing and continue to strengthen that B2C business. And as noted by Anita, we are also expanding into Denmark now. And we are quite excited to see how we can do in that market too.

Unknown 2
12:14 - 12:41

Wonderful. And then a final question from me, today you talked about some added resources in the U.S. negatively impacting the margins there. And you expect us to start paying off in 2025 and beyond. Could you maybe just elaborate a bit on what type of ramp up we should expect going forward from 2025 onwards? Is it back to historical levels or how should we think?

Anita Johansen
12:42 - 13:18

I think it's fair to say that when we launched our strategy back in October last year, we talked about our financial targets. So, we have a target to say in 2028, we want to have an EBITDA margin at or above 25%. We also communicated that this year is a transition year. So this year we are not expecting any specific growth versus last year. But then gradually we will expect an increase in the EBITDA from 2025. and beyond that. If that was your question.

Unknown 2
13:19 - 13:23

Perfect. Thank you. That's all for me.

Anita Johansen
13:23 - 13:24

Thank you, Philip.

Operator
13:31 - 13:37

There are no more questions at this time, so I hand the conference back to the speakers for any closing comments.

Anita Johansen
13:39 - 14:02

Next slide please. Okay. With no more questions, I want to say, our financial calendar is shown here on the last slide. Our next interim report, the Q3 report will be out on October 22nd. And then after that we have the year-end report on January 28th next year. I just want to say thank you all for listening and have a wonderful day.

Continue to the webcast
Pierce Group, Audiocast, Q3'26
Language: English11/13/2026, 8:00 AM
Göran Dahlin Good morning, everyone, and welcome to Pierce Group's presentation of our Q3 2026 interim results. Next slide, please. I am Göran Dahlin, CEO of Pierce Group, and I am with Fredrik Kjellg…
Surgical Science Sweden, Audiocast, Q3'26
Language: English11/12/2026, 10:00 AM
Tom Englund Hi everyone, and welcome to this earnings call for Surgical Science for the third quarter of 2026. My name is Tom Englund. I am the CEO. And with me today is our CFO, Anna Ahlberg. I wil…
ExpreS2ion Biotech – Presentation of Q3 2026 Interim Report
Language: English11/12/2026, 9:00 AM
ExpreS2ion is expected to release its Q3 2026 interim report on 12 November 2026. Later the same day at 10.00, ExpreS2ion’s CEO Bent U. Frandsen and CFO Keith Alexander will present the results and answer questions in a live online event.
Meko Services AB, Q3'26
Language: English11/12/2026, 8:00 AM
Pat Thank you. Good morning, and welcome to MEKO's presentation of the third quarter of 2026. I am here with our CFO, Christy Johansson, and I will begin with an overview of the quarter and some of th…
WeSports Group, Audiocast, Q3'26
Language: English11/12/2026, 8:00 AM
Unknown 1 It. Ted Sporre Welcome to our Q3 release presentation. As you know, we have already shared preliminary figures for sales and EBITDA for this quarter, but today we complete the picture. We wi…
Nordrest Holding, Audiocast, Q3'26
Language: Swedish11/12/2026, 8:00 AM
Thomas Dahlstedt Hej och välkomna! Vi ska idag presentera Nordrests senaste kvartal och tillika resultatet för perioden. Jag som pratar nu heter Thomas Dahlstedt och är grundare och tillika VD för bol…
Karnov Group, Audiocast, Q3'26
Language: English11/12/2026, 8:00 AM
Pontus Bodelsson Welcome, everyone, to Karnov Group's earnings conference, where we will present the outcome of the third quarter of 2026. Please go to slide two. I am Pontus Bodelsson, President and…
Fasadgruppen Group, Audiocast, Q3'26
Language: English11/12/2026, 7:15 AM
Magnus Blomberg Perfect. Good morning and welcome to the Fasadgruppen presentation of our results for the third quarter 2026. My name is Magnus Blomberg. You have met me before. I am the CFO of Fasadg…
Munters AB, CMD
Language: English11/11/2026, 1:00 PM
Lena Dauvergne Good. Good afternoon everyone, and a warm welcome to Stockholm, to ESSEX and to Montage Capital Markets Day 2026. Montage Capital Markets Day 2026. It is really good to see so many of y…
Cinclus Pharma, Audiocast, Q3'26
Language: English11/11/2026, 1:00 PM
Christer Ahlberg Thank you. Hello and welcome to the Cinclus Pharma third quarter 2026 earnings call. I am Christer Ahlberg, CEO of Cinclus Pharma, and with me today is our CFO, Magnus Christensen. We…
Proact IT, CMD
Language: English11/11/2026, 12:30 PM
Unknown 1 The world of data is constantly changing. Breaches are rising, and attacks are getting more advanced. Regulation drives the need for data sovereignty. Data has to be available. Critical busi…
Ferronordic AB, Audiocast, Q3'26
Language: English11/11/2026, 9:00 AM
Henrik Good morning, everyone, and welcome to our presentation of the third quarter of 2026. During the quarter, we saw higher earnings, and growing aftermarket revenue was up 15% to 1.2 billion Swedi…
BICO, Audiocast, Q3'26
Language: English11/11/2026, 9:00 AM
Anders Fogelberg Good morning, everyone, and welcome to BICO's earnings call for the third quarter of 2026. I am Anders Fogelberg, President and CEO of BICO. And joining me today is our Group CFO, Ewa…
Catena Media, Audiocast, Q3'26
Language: English11/10/2026, 5:00 PM
Manuel Stan Good afternoon. Good evening, everyone. Welcome to the Catena Media Q3 Interim Report. I am Manuel Stan and today I'm joined by our Chief Financial Officer, Michael Gerrow. Today we will b…
Ellos Group, Q3'26
Language: English11/10/2026, 8:00 AM
Hans Ohlsson Live. Good morning, everyone, and welcome to the second presentation for Ellos Group as a listed company. We have 45 minutes today for the presentation. And there is a hard stop. After th…
Scandic Hotels Group, Audiocast, Q3'26
Language: English11/10/2026, 8:00 AM
Jens Mathisen Thank you so much, and good morning, everyone, and thank you for joining us for the Q3 presentation. I am Jens Mathisen, CEO of Scandic. And joining me is our CFO, Pierre Carstensen. We…
Svevik Industri, Q3'26
Language: Swedish11/6/2026, 9:00 AM
Johan Hårdén Tack så mycket! Hello and welcome to this hearing regarding the Q3 2026 interim report. We have an agenda where we intend to introduce ourselves to all the new shareholders as well. Kort…
Attendo, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
Martin Tivéus Good morning, everyone, and thank you for joining us. Today, we will present our results for the third quarter of 2026. I am pleased to announce that this is the strongest quarter for At…
Cavotec, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
David Pagels Good morning and welcome to Cavotec's Q3 2026 presentation. I am David Pagels, the CEO of Cavotec. And together with me today, I have our new CFO, Christoffer Robertsson. I would like to…
Fractal Gaming Group, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
Jonas Good morning, everyone, and welcome to Fractal's Q3 2026 presentation. Today, we'll take you through our results, the progress that we've made, and our priorities ahead after a difficult first h…